Li Zhaohui, Zhang Zengyuan, Rosen Steven T, Feng Mingye
Department of Immuno-Oncology, Beckman Research Institute, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
Department of Molecular Microbiology & Immunology, University of Southern California, CA, USA.
Cell Insight. 2024 Feb 3;3(2):100150. doi: 10.1016/j.cellin.2024.100150. eCollection 2024 Apr.
As the dynamic evolution of SARS-CoV-2 led to reduced efficacy in monoclonal neutralizing antibodies and emergence of immune escape, the role of bispecific antibodies becomes crucial in bolstering antiviral activity and suppressing immune evasion. This review extensively assesses a spectrum of representative bispecific antibodies targeting SARS-CoV-2, delving into their characteristics, design formats, mechanisms of action, and associated advantages and limitations. The analysis encompasses factors influencing the selection of parental antibodies and strategies for incorporating added benefits in bispecific antibody design. Furthermore, how different classes of parental antibodies contribute to augmenting the broad-spectrum neutralization capability within bispecific antibodies is discussed. In summary, this review presents analyses and discussions aimed at offering valuable insights for shaping future strategies in bispecific antibody design to effectively confront the challenges posed by SARS-CoV-2 and propel advancements in antiviral therapeutic development.
随着新冠病毒(SARS-CoV-2)的动态演变导致单克隆中和抗体的效力降低以及免疫逃逸的出现,双特异性抗体在增强抗病毒活性和抑制免疫逃逸方面的作用变得至关重要。本综述广泛评估了一系列靶向SARS-CoV-2的代表性双特异性抗体,深入探讨了它们的特性、设计形式、作用机制以及相关的优势和局限性。分析涵盖了影响亲本抗体选择的因素以及在双特异性抗体设计中纳入额外益处的策略。此外,还讨论了不同类别的亲本抗体如何有助于增强双特异性抗体的广谱中和能力。总之,本综述进行了分析和讨论,旨在为制定双特异性抗体设计的未来策略提供有价值的见解,以有效应对SARS-CoV-2带来的挑战,并推动抗病毒治疗开发的进展。